A long-mysterious condition that has quietly contributed to premature culling and lost lifetime productivity in dairy herds may finally be coming into focus. New research from the University of Guelph shows bovine spastic syndrome, or Crampy, is not just unpredictable, but genetically influenced — and increasingly manageable through selection.
The study, which analyzed more than 54,000 Holstein cattle across 678 Canadian herds, identified multiple genomic regions associated with the condition and demonstrated that incorporating this information into breeding programs improves prediction accuracy. Previous work had suggested a genetic link, but this large-scale dataset both quantifies heritability and pinpoints specific regions tied to disease risk.
What is Crampy?
This chronic neuromuscular disorder typically appears in adult cattle, most often between 2 and 7 years of age. It is characterized by intermittent muscle spasms, usually beginning in the hind limbs. Early signs can be subtle, including stiffness or brief tremors, but episodes may progress in severity and duration over time.
As the condition advances, mobility declines. In many cases, affected animals are ultimately removed from the herd due to welfare concerns and reduced productivity.
Crampy has long been suspected to have a genetic component, but the lack of clear markers has limited the ability to act on that assumption. Environmental and metabolic factors have been explored, yet they have not consistently explained disease occurrence. As a result, control has relied on observation and culling rather than prevention.
What the New Research Shows
The new study confirms Crampy is moderately heritable, meaning genetics plays a meaningful — but not exclusive — role in whether an animal develops the condition.
Researchers identified 41 significant single nucleotide polymorphisms associated with Crampy across the genome. Many of these markers are located near genes involved in neuromuscular signaling, ion transport and muscle contraction, which closely align with the clinical signs observed in affected cattle.
The analysis also uncovered genetic correlations with mineral-related traits, including calcium and zinc balance. While these relationships do not establish causation, they provide biological plausibility and suggest disruptions in mineral handling and nerve excitability may contribute to disease expression.
From a selection standpoint, one of the most important findings is the improvement in genomic prediction accuracy. When genomic information was included, reliability of breeding values increased by up to 17% compared to traditional approaches. In practical terms, this means producers and breeding programs can identify higher-risk animals with greater confidence, even before clinical signs appear.
Importantly, the study found no strong antagonistic relationships with major production traits, indicating selection against Crampy can be incorporated into existing breeding goals without compromising performance.
What Does This Mean for Treatment and Management?
There is no effective treatment for Crampy. With no reliable medical or nutritional intervention available, control has historically depended on management decisions:
- Culling severely affected animals
- Reducing handling stress to limit episode triggers
- Avoiding use of affected animals in breeding decisions
This has made long-term control difficult under traditional approaches and reinforced the need for preventive strategies.
A Shift Toward Prevention
What this research changes is the ability to act proactively.
With clearer genetic markers and improved prediction tools, breeding decisions can play a central role in reducing the condition over time. This also increases the importance of identifying and recording affected animals at the herd level.
For bovine spastic syndrome prevention:
- Record and track suspected Crampy cases consistently
- Flag affected cow families when making breeding decisions
- Work with genetic advisers as selection tools become available
- Avoid retaining replacements from clearly affected lines
Crampy remains a challenging condition, but the path forward is becoming more defined — shifting the focus from reacting to individual cases to systematically reducing risk at the population level.
